Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
Journal article published in 2017 by
Beate Jahn,
Ursula Rochau,
Christina Kurzthaler,
Michael Hubalek,
Rebecca Miksad,
Gaby Sroczynski 
,
Mike Paulden,
Marvin Bundo,
David Stenehjem ,
Diana Brixner,
Murray Krahn ,
Uwe Siebert
,
Mike Paulden,
Marvin Bundo,
David Stenehjem ,
Diana Brixner,
Murray Krahn ,
Uwe Siebert
This paper is made freely available by the publisher.
Full text: Download
Data provided by 